Evidence map›Paper›PMID 29020199›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Viral Surveillance in Serum Samples From Patients With Acute Liver Failure By Metagenomic Next-Generation Sequencing.

Sneha Somasekar, Deanna Lee, Jody Rule, Samia N Naccache, Mars Stone, Michael P Busch, Corron Sanders, William M Lee, Charles Y Chiu

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genomoviruses in Liver Samples ofMicroorganisms · 2024
    Article
  14. Expansion ofViruses · 2023
    Article
  15. Review
  16. Review
  17. Management of Acute Liver Failure: Update 2022.Seminars in liver disease · 2022
    Article
  18. Hepatitis of unknown aetiology in children - epidemiological overview of cases reported in Europe, 1 January to 16 June 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sneha SomasekarDepartment of Laboratory Medicine, University of California San Francisco (UCSF).
Deanna LeeDepartment of Laboratory Medicine, University of California San Francisco (UCSF).
Jody RuleDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas.
Samia N NaccacheDepartment of Laboratory Medicine, University of California San Francisco (UCSF).
Mars StoneBlood Systems Research Institute, San Francisco, California.
Michael P BuschDepartment of Laboratory Medicine, University of California San Francisco (UCSF).
Corron SandersDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas.
William M LeeDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas.
Charles Y ChiuDepartment of Laboratory Medicine, University of California San Francisco (UCSF).
University of California, San Francisco · USThe University of Texas Southwestern Medical Center · USBlood Systems Research Institute · US

Funding

Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious AgentsR01HL105704 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2011 to 2020
$5.9M
NHLBI NIH HHS R01 HL105704
6 · The paper itself

Abstract

backgroundTwelve percent of all acute liver failure (ALF) cases are of unknown origin, often termed indeterminate. A previously unrecognized hepatotropic virus has been suspected as a potential etiologic agent.

methodsWe compared the performance of metagenomic next-generation sequencing (mNGS) with confirmatory nucleic acid testing (NAT) to routine clinical diagnostic testing in detection of known or novel viruses associated with ALF. Serum samples from 204 adult ALF patients collected from 1998 to 2010 as part of a nationwide registry were analyzed. One hundred eighty-seven patients (92%) were classified as indeterminate, while the remaining 17 patients (8%) served as controls, with infections by either hepatitis A virus or hepatitis B virus (HBV), or a noninfectious cause for their ALF.

resultsEight cases of infection from previously unrecognized viral pathogens were detected by mNGS (4 cases of herpes simplex virus type 1, including 1 case of coinfection with HBV, and 1 case each of HBV, parvovirus B19, cytomegalovirus, and human herpesvirus 7). Several missed dual or triple infections were also identified, and assembled viral genomes provided additional information on genotyping and drug resistance mutations. Importantly, no sequences corresponding to novel viruses were detected.

conclusionsThese results suggest that ALF patients should be screened for the presence of uncommon viruses and coinfections, and that most cases of indeterminate ALF in the United States do not appear to be caused by novel viral pathogens. In the future, mNGS testing may be useful for comprehensive diagnosis of viruses associated with ALF, or to exclude infectious etiologies.

Indexed as

AdolescentAdultDNA, ViralFemaleGenome, ViralHepatitis, Viral, HumanHepatitis VirusesHigh-Throughput Nucleotide SequencingHumansLiver Failure, AcuteMaleMetagenomicsMiddle AgedRetrospective StudiesRNA, ViralYoung AdultDNA, ViralRNA, Viralindeterminate ALFmetagenomic next-generation sequencingpathogen discoverySURPI computational pipelineviral hepatitis

Identifiers

PMID29020199
PMCPMC5848299
OpenAlexW2736894590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.